search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
FORMULATING FOR MILDNESS 9%act SLMI 3%act CAPB


6%act SLMI 3%SMCT, 3%act CAPB 4.5%SLMI, 4.5%SMCT, 3%act CAPB


18000 16000 14000 12000 10000 8000 6000 4000 2000 0


3%act SLMI 6%act, 3%act CAPB 9%act SMCT 3%act CAPB


35 30 25 20 15 10 5 0


57 14 Day cumulative Skin Irritation 0.5% Active pH 6.0


0


1


2


3 NaCI / % (w/w) Figure 4: Viscosity response of SLMI and SMCT with CAPB effect of NaCl


the integrity of the lipid barrier in the stratum corneum and thus increase the skin permeability therein.4


Surfactant solutions,


when topically applied can also swell corneocyte proteins, resulting in the removal of natural moisturising factors. This can increase and enhance the penetration of irritant chemicals into the viable epidermis.5 The belief here is that the penetration


directly leads to skin dryness and increases the potential and likelihood of the development of skin irritation. Additionally, surfactants can demonstrate an effect on the biology of the stratum corneum. As an example, sodium lauryl ether sulfates are reported to inhibit the enzymes that control and regulate desquamation within the stratum corneum. This can lead to scaling, dryness of the skin and result in impairment of the skin barrier function.6


Mildness testing We have mentioned that specifically in the case of shampoos, mildness to the eyes is exceptionally important. The advent of the


Pureact WS Conc & CAPB


Figure 5: Relative irritation potential of anionic surfactants via human volunteer repeat insult patch testing


introduction of a ban on animal testing as part of the current cosmetics directive, its prohibition in other markets outside of the EU, and the general feeling of consternation by consumers, has meant alternative in vitro methods to support mildness and ‘no tears’ claims for personal care ingredients and finished products, particularly the red blood cell test.7 Investigation of the results and test data


from several studies has correlated the relationship between the red blood cell test data for a series of surfactant classes and in vitro eye irritation data.6


The observations


demonstrated a clear relationship between reported eye irritation data and the concentration of surfactants and finished products (in this case shampoos), required to result in breakage of cytoplasmic membranes (cell haemolysis) and denaturation of haemoglobin. Additionally, the data demonstrated a trend


that the order of irritancy followed this path: cationics (demonstrating severe eye irritation)


Conc & CAPB & Iselux Pureact WS


Pureact WS Conc & CAPB & Pureact I-78


> anionics and amphoterics (moderate) > non-ionics (moderate to non-irritant). The red blood cell test continues to be utilised as a tool to screen shampoo formulations for their mildness to mucosal membranes. One additional example uses red blood cell test data to demonstrate that increasing the proportion of an amphoteric surfactant, e.g. Cocamidopropyl betaine, as part of an anionic/amphoteric blend significantly reduces the potential for irritancy.8


Skin mildness testing The mildness of surfactants on skin has also been correlated with their tendency (or lack of) to interact and denature zein proteins.9 The study demonstrated that for a series of surfactants, skin patch test data correlate well very well with the results from zein dissolution tests.


Another benefit from this study is that the data has allowed for the development of a structure-activity relationship that can accurately predict the zein dissolution data for surfactant structures. Mildness of surfactants has also been linked to their effects on skin lipids.10


Results of the work reported


demonstrated that lipid solubilisation and disruption tests can produce data that proports to the inverse of the protein dissolution data. An example cited refers to


Pureact WS Conc & CAPB & Pureact LSR


Pureact WS Conc & CAPB & Pureact Gluco C


Pureact WS Conc & Empicol® CDL-60P


alkylpolyglucosides, well known for being mild and non-ionic in character, typically have low zein dissolution scores (therefore low protein disruption), also report high lipid bilayer disruption. This indicates that alkylpolglucosides can potentially be drying to the skin. Obviously, there will always be anomalous


Figure 6: Foam characteristics of co-surfactants blended with sodium methyl cocoyl taurate and cocamidopropylbetaine


www.personalcaremagazine.com


results, and the report surprisingly reveals that isethionates deliver a rather unique combination of both low zein dissolution scores and low lipid bilayer disruption effect. One final observation of note in that investigating the increasing the level of amphoterics (cocamidopropyl betaine) as a secondary surfactant alongside an anionic surfactant will reduce the zein dissolution score. However, at higher levels of cocamidopropyl betaine there is a noticeable increase in


4


5


6


PC November 2022 PERSONAL CARE


Viscoisty / (Cp20˚C)


Relative Irritation Score


Sodium Lauryl Sulfate Sodium Laureth Sulfate Cocamidopropyl Betaine


Sodium Lauroyl Methyl Isethionate Sodium Cocoyl Isethionate Sodium methly Cocoyl Taurate Sodium Lauroamphoacetate Decyl Glucoside


Sodium Lauryl Glycinate Deionised Water


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92